Navigation Links
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Date:5/21/2008

TOKYO, May 21 /PRNewswire/ -- Daiichi Sankyo Co., Ltd. announced today that it has entered into an agreement to acquire the privately held firm, U3 Pharma AG, a German biotechnology company focusing on research into antibodies for the treatment of cancer.

Daiichi Sankyo will purchase 100 percent of the stock and make a one-time payment of 150 million Euros ($235 million dollars) for the company. Closure of the transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and customary closing conditions.

U3 Pharma, which is based in Martinsried, Germany, was founded by Professor Axel Ullrich of the Max Planck Institute of Biochemistry, whose pioneering gene technology-based and oncology-focused research led to the development of the oncology blockbusters Herceptin(R) and Sutent(TM)*. U3 Pharma was established in 2001 and currently employs 27 people, the majority of whom work directly in research and development.

U3 Pharma's investors include Alta Partners, Atlas Venture, E. de Rothschild Investment Partners, Life Science Partners and Karsten Henco, as well as private individuals from the biotech and pharmaceutical industries.

U3 Pharma's pipeline of novel targeted therapeutics includes programs focusing on fully-human antibodies as potential therapies for breast, lung and colorectal cancers, among others. The company's lead product, which is being co-developed with Amgen, is U3-1287 (AMG 888), the first fully-human anti-HER3 monoclonal antibody (mAb) to inhibit oncogenic signaling and tumor proliferation. The companies intend to initiate clinical development of this compound this year.

Daiichi Sankyo's current novel therapeutics portfolio for worldwide commercialization includes CS-1008, an oncologic agent to combat malignant neoplasms, which is in Phase 2. For commercialization only in Japan, Daiichi Sankyo has the rights to market denosumab, or AMG 162, which is licensed from Amgen. In Japan, t
'/>"/>

SOURCE Daiichi Sankyo Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
2. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
3. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ont Applied BioSciences has turned to MBI Internat...mmercial viability of an important bio-based produ... the gap between research and commercialization th...logies. MBI’s unique “Collaborative De...echnological uncertainties, which impede new techn...
(Date:12/2/2008)...Newswire/ -- GeneGo, Inc., the leading systems bio...as become a certified GeneGo Center of Excellence....cess to GeneGo,s MetaCore data analysis suite, tra... is a world-class biomedical research facility run...t many departments, including research in cancer, ...
(Date:12/2/2008)...Newswire/ -- Intradigm Corporation, a leading,dev...i) therapeutics, today,announced the issuance of ...,and Compositions for Controlling Efficacy of RNA ... the seminal research of Philip Zamore, Ph.D., the... and Professor of Biochemistry,& Molecular Ph...
(Date:12/2/2008)...s an Innovation Point as a Stand-Alone Product , ...The National Geographic Society has used a one-of-...-certified as a national leader in energy efficien...logy, manufactured by StrionAir of Louisville, Col...ts for its LEED-EB 2.0* re-certification applicati...
Breaking Biology Technology: DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product 2The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 3National Geographic Uses Air Filtration in Bid To Be an Energy, Environmental Leader 2
...ovation born of "creative laziness" in the School ...rsity of Wisconsin-Madison is saving time and mone...y research. , ,"It allows us to conduct research a...ing technology into the classroom much more readil...alism. "It,s become a valuable, powerful classroom...
...Internet Photonics announced today that TDS Metroc...gent Wavelength platforms to deliver new Ethernet ...ders. The service, called MegaDATA and GigaDATA wi...and wholesale applications. , ,According to Ben Go...aDATA provides a managed Ethernet service to meet ...
...has received from NorthStar Economics an advance c... for Wisconsin companies seeking information about...nd his team have agreed to exclusively excerpt the...h and final installment is: , , Seed-Stage Ventur...comparatively modest capital amounts provided to a...
...ral technology-based companies, I frequently recei.... One source that is often overlooked is governme...vation Research (SBIR)/Small Business Technology T...lients with assistance concerning SBIR/STTR applic... eligibility requirements, contract negotiations, ...
Other Biology Technology:UW Journalism School Software Expands Web-Based Research 2UW Journalism School Software Expands Web-Based Research 3Seed-Stage Venture Financing 2Seed-Stage Venture Financing 3Seed-Stage Venture Financing 4Seed-Stage Venture Financing 5SBIR/STTR Programs: Free Money or an Invitation to Governmental Bureaucracy 2SBIR/STTR Programs: Free Money or an Invitation to Governmental Bureaucracy 3
(Date:12/2/2008)...ies are growing faster than anywhere else in the w...gists are studying the urban environment and effec...ant ecological changes in Africa,s history is bein...of Twente has reviewed the problem in the current ...s "A hundred years ago 95% of the African populati...
(Date:12/2/2008)...is undergoing rapid transformation due to climate ...d Envisat satellites have been providing satellite...ong term data sets in combination with ESA,s futur...dopted European Commission policy called ,The Euro...highlights new opportunities in the region such as...
(Date:12/1/2008)...els in fish are prompting widespread consumption a...ch species are safe to eat. Now researchers at Nor...l that will help scientists and regulators around ... fish with high mercury levels a breakthrough tha... by developing health advisories for specific wate...
(Date:12/1/2008)...nal Academy of Sciences will hold a colloquium to ... the nature of niches of organisms. Leading resear...ct future patterns of distribution and even evolut..., phylogenetics, and biodiversity informatics deal...e Sackler Colloquium series, the event will take p...
Breaking Biology News(10 mins):ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation 14199 1Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation 14199 2Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation 14199 3U S Syphilis Rate Grows for 7th Year in Row 14196 1U S Syphilis Rate Grows for 7th Year in Row 14196 2U S Syphilis Rate Grows for 7th Year in Row 14196 3ASN members visit Capitol Hill to promote World Kidney Day and CKD awareness 14195 1ASN members visit Capitol Hill to promote World Kidney Day and CKD awareness 14195 2Biomatricas PCRboost 28TM 29 Enables 5 Fold Improvement in Amplification of Difficult Samples 3911 1Biomatricas PCRboost 28TM 29 Enables 5 Fold Improvement in Amplification of Difficult Samples 3911 2
...dark Arctic Ocean, the marine bacterium Colwellia ...ow 5° degrees Celsius. How does the bacterium func...ntists at The Institute for Genomic Research (TIGR... psychrerythraea,s genome. , That genome analysis,... of Sciences (PNAS) Online Early Edition July 25-2...
...man embryonic stem cell research receives a tremen...re also exploring the potential of adult stem cell...her difficulties. Although adult stem cell researc...nd embryonic stem cells, adult stem cells are extr... a lab dish. Now, as reported in the May 6 issue o...
...versity of Washington and their colleagues at othe...ly extend the lifespan of mice while reducing the ...ll be published online by the journal Science on M...ry of aging. , The theory suggests that very react...ging to the body at the cellular level. Those reac...
...particles that they developed, University at Buffa...nes into the brains of living mice with an efficie...ors and with no observable toxic effect, according...the National Academy of Sciences. , The paper desc... complexes to activate adult brain stem/progenitor...
Other Biology News:Deep thinking: Scientists sequence a cold-loving marine microbe 2Deep thinking: Scientists sequence a cold-loving marine microbe 3Researchers discover mechanism for multiplying adult stem cells 2Researchers extend mouse lifespan by protecting against free radicals 2Researchers extend mouse lifespan by protecting against free radicals 3Using nanoparticles, in vivo gene therapy activates brain stem cells 2Using nanoparticles, in vivo gene therapy activates brain stem cells 3
...re easily imported for data analysis , A...edious spot, template a... Extensive background and signal options to op... Characterize more precisely through group...
This is a PYREX replacement Allihn condenser with a 34/45 inner joint on the bottom for the No. CLS3840-S 125mL extractor system. The tubulation O.D. on the condenser is 10mm.
...tains 400 unique human proteins on a 1x3 inch nitr...ss section of all cellular proteins, are arrayed i...al control proteins and a specific chip layout gua...p protein microarrays are high-density protein bio...
...tains 400 unique human proteins on a 1x3 inch nitr...ntracellular proteins (IP) according to Gene Ontol...or high-quality results. Additional control protei...ity and reproducibility., UNIchip protein microarr...
Biology Products: